logo
Select company
Select metric
$ -79.73MEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)
VS
Market
9
Sector
23
Industry
34
History
-
$ 3.13Close
$ 1.26 - $ 4.19 52-Week Range
Ticker Information

Ticker

MGX

Company Name

METAGENOMI INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

METAGENOMI INC - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MGX - EBITDA Historical data
DateDepreciation, Amortization & AccretionEarning Before Interest & Taxes (EBIT)Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)
6/30/2025$ 10.56M$ -90.29M$ -79.73M
3/31/2025$ 10.28M$ -83.36M$ -73.08M
12/31/2024$ 10.05M$ -83.57M$ -73.52M
9/30/2024$ 9.68M$ -75.53M$ -65.85M
12/31/2023$ 8.41M$ -60.23M$ -51.81M
12/31/2022$ 3.02M$ -40.93M$ -37.9M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • METAGENOMI INC's latest trailing twelve months (TTM) EBITDA stands at $ -37.9M.
  • Over the past 5 years, METAGENOMI INC's average EBITDA has been $ -63.65M.
  • The median EBITDA for METAGENOMI INC during this period was $ -69.47M
  • METAGENOMI INC reached its highest EBITDA over the past 5 years at $ -37.9M.
  • The lowest EBITDA recorded by METAGENOMI INC in the same timeframe $ -79.73M

METAGENOMI INC's EBITDA vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA Benchmarks
CompanyEBITDA
ICCC : IMMUCELL CORP $ 4.47MWHWK : WHITEHAWK THERAPEUTICS INC $ -9.91MMRSN : MERSANA THERAPEUTICS INC $ -65.59MIRD : OPUS GENETICS INC $ -58.24MVRCA : VERRICA PHARMACEUTICALS INC $ -38.54MHYFT : MINDWALK HOLDINGS CORP $ -19.99MEQ : EQUILLIUM INC $ -19.7MBRNS : BARINTHUS BIOTHERAPEUTICS PLC $ -60.1MDOMH : DOMINARI HOLDINGS INC $ -18.5MIVVD : INVIVYD INC $ -106.81M

Definition of Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

[Calculation] EBITDA is a non-GAAP accounting metric that lets investors asses profitability net of expenses dependent on financing decision, tax strategy and depreciation schedules. It is calculated by adding depreciation and amortisation expenses [DepAmor] back to [EBIT].
EBIT + DepAmor
(=) EBITDA
EBITDA for METAGENOMI INC is calculated as follows: EBIT [ $ -40.93M ] + DepAmor [ $ 3.02M ]
(=) EBITDA [ $ -37.9M ]

MGX - Earnings Before Interest Taxes & Depreciation Amortization (EBITDA), Last 5 years

$ -79.73M

Minimum

Jun 30, 2025

$ -37.9M

Maximum

Dec 31, 2022

$ -63.65M

Average

$ -69.47M

Median

EBITDA Benchmark Analysis

The chart above depicts the distribution of EBITDA for companies in the Total Stock Market. The average EBITDA of the companies is $ 58.77M with a standard deviation of $ 166.95M.
The following table provides additional summary stats:
EBITDA in the Market:
filtered constituents3.25K
min$ -493.3M
max$ 590.6M
average$ 58.77M
median$ 8.83M
std$ 166.95M